In order to standardize a polymerase chain reaction (PCR)-based method of Pneumocystis detection, we describe the development of an improved PCR method that targets the Pneumocystis mtLSUrRNA gene. Design of a new primer pair and PCR program with suitable parameters and optimization resulted in a simpler and faster single-round amplification assay. The sensitivity of the novel Pneumocystis genus-specific PCR proved comparable to the reference nested PCR. The improvement that this new PCR assay offers in the detection and epidemiological studies of Pneumocystis spp. infection in research laboratories is discussed.
Introduction
Polymerase chain reaction (PCR)-based approaches that combine high sensitivity and specificity are the methods of choice for diagnosis of Pneumocystis infection and epidemiological studies of this fungus, which cannot be cultured continuously outside the mammalian lung.
Because of the unavailability of full-scale annotation of Pneumocystis genomes and the scarcity of diverse Pneumocystis spp. gene sequences in databases, the generally accepted method for detecting Pneumocystis DNA in mammalian respiratory samples is amplification of part of the gene coding for Pneumocystis mitochondrial large subunit ribosomal RNA (mtLSUrRNA), of which the Pneumocystis spp.-specific primers (pAZ102-H and pAZ102-E) were first described in 1990 by Wakefield et al. [1] . The consistent genetic diversity detected between mtLSUrDNAs of Pneumocystis isolated from different mammals and correlated with the host species also initiated the use of this target as a genotyping and phylogenetic tool in epidemiological studies of Pneumocystis infection [2] . The mtLSUrRNA target is of great interest in terms of PCR sensitivity as multiple copies of the mitochondrial genome of Pneumocystis are present in one organism [3] . It explains that, despite the evaluation of other gene targets and PCR methods, this mtLSUrRNA PCR has easily spread across worldwide clinical or research laboratories studying Pneumocystis infection in various mammals.
However, mtLSUrRNA PCR methods are not currently standardized across laboratories in terms of reaction conditions. They can be time consuming and sometimes exhibit poor sensitivity. For example, nested PCR protocols are often used to detect very low parasite burdens encountered in human noninvasive samples such as oropharyngeal washings or in lung samples from Pneumocystis-colonized wild mammals. However, nested PCR is time consuming, open to considerable risk of contamination and final Taq error frequency, and has low cost efficiency. For all these reasons, single-round PCR is preferable to nested PCR in clinical and research routine laboratories.
Also of particular importance when optimizing a PCR protocol is the melting temperature (Tm) of primers. Unfortunately, we found that the two classic primers, pAZ102-H and pAZ102-E, have a Tm difference >5
• C (ie, 48.68
• C and 54.01
• C, respectively, calculated using the nearestneighbor method [4] ). Moreover, as a result of the recent fully sequenced Pneumocystis mitochondrial genomes [5, 6] , we highlighted a mismatch between primer pAZ102-H and the P. jirovecii mtLSUrDNA sequences (Fig. 1A) . Six mismatches were also encountered between the internal primer pAZ102-Y (initially designed to amplify P. jirovecii by nested PCR [7] ) and P. carinii and P. murina mtLSUrDNA sequences (Fig. 1B) . This could affect both the stability of the primer-template duplex and the efficiency with which the polymerase extends the primer, thus potentially leading to biased results or even PCR failure when this primer is used to amplify Pneumocystis DNA from rodents. These mismatches could also have a substantial negative impact on the exploitation of Pneumocystis mtLSUrDNA sequences for genotyping or phylogenetic studies. Thus, our aim in this study was to develop an improved single-round, rapid, highly sensitive, and Pneumocystis genus-specific PCR that targets mtLSUrRNA for use in research laboratories that are equipped, or not, with a real-time PCR thermal cycler.
Materials and methods

Design of primers and PCR parameters
Primers were developed using multiple sequence alignments [8] of Pneumocystis mtLSUrDNA sequences recovered from a wide range of mammal host species and [7] . Pneumocystis sequences were recovered from the newly sequenced Pneumocystis mitochondrial genomes from which GenBank accession numbers are given [5] [6] . Identical nucleotides between primers and Pneumocystis sequences are denoted by dots. available in databases. New primer pairs in conserved regions of the gene were designed after assessing different parameters (eg, Tm close to 60
• C, close Tm for the two primers, GC content, potential for hairpins, homo-or hetero-dimers, quality, and linguistic complexity) with Fast-PCR v.6.0 [9] and Oligocalc [10] . PCR primer specificity was checked by a BLAST search at the National Center for Biotechnology Information (NCBI) against the nr database (http://www.ncbi.nlm.nih.gov/). To check the target specificity of the novel primer pair, Primer-BLAST [11] was also performed using default specificity parameters against the entire NCBI nr database or against the NCBI nr database with organisms limited to other lung pathogens such as Histoplasma capsulatum, Aspergillus fumigatus, Candida albicans, Cryptococcus neoformans, Scedosporium spp., Rhizopus oryzae, and Coccidioides spp. Furthermore, the new primer pair was evaluated by SYBRGreen quantitative PCR (qPCR) assay performed on a qPCR platform Rotor-Gene 6000 (Corbett Life Science, Concorde, NSW, Australia). Reactions were achieved in a final volume of 15 µl containing 2 µl of the appropriate template (serial dilutions of plasmid in 25 ng of rat DNA), 1 X Brilliant II SYBR Green qPCR Master Mix (Agilent Technologies, Santa Clara, CA, USA), and 500 nM of each primer. The optimal thermal cycling conditions were as follows: 10 min at 95
• C followed by 50 amplification cycles of 10 s at 95
• C, 15 s at 59
• C (data acquisition at the end of annealing step), and 24 s at 72
To determine the optimal PCR conditions, a P. carinii mtLSUrRNA PCR product (obtained with primers pAZ102-H and pAZ102-E) was cloned into the pCR 2.1-TOPO Vector with the TOPO TA Cloning kit (Invitrogen LIfe Science Technologies, St. Petersburg, FL, USA), and 10-fold dilution series of the plasmid DNA were tested.
PCR sensitivity and limit of detection
The sensitivity and limit of detection (LOD) of our new PCR were assessed after analyzing 10-fold serial dilutions of P. carinii mtLSUrDNA plasmids (2.10 6 -2.10 −1 copy number/reaction). In order to estimate the LOD concentration of the target in a background matrix of DNA representative of the DNA that will be isolated from the lung samples being examined, 1 µl of DNA extracted from a Pneumocystisfree Lou nu/nu rat lung (25 ng/µl; Institut Pasteur de Lille, France) was added to each plasmid dilution in the reaction mixtures. DNA amplification was carried out using a PTC 200 thermocycler equipped with a heated lid (MJ Research, Foster City, CA, USA). PCR products were analyzed by electrophoresis in a 2% agarose gel and visualized after ethidium-bromide staining. Then, PCR products were sequenced in both directions using a model ABI 377 number/reaction were each tested in 10 replicates. For comparison, the plasmid dilutions were tested following our in-house first-round (with primers pAZ102-H and pAZ102-E) and nested (with primers pAZ102-X and pAZ102-Y) PCRs under the following conditions: 50-µL reaction mixture containing 20 µl of template DNA, 1 X Buffer (Diamond Taq polymerase, Eurogentec, Seraing, Belgium), 3 mM MgCl 2 , 400 µM (each) dNTP, 1 µM (each) oligonucleotide primer, and 1U of Diamond Taq polymerase (Eurogentec, Seraing, Belgium). Conditions for amplification in the first-round PCR were 10 cycles comprising 1.5 min at 94
• C, 1.5 min at 65
• C decrease per cycle, and 2 min at 72
followed by 30 cycles comprising 1.5 min at 94
• C, 1.5 min at 55
• C, and 2 min at 72
• C [12] . Nested PCR was then performed as described elsewhere [13] . Serial dilutions of plasmid were tested in duplicate by the novel and in-house first-round and nested PCRs.
PCR specificity
The new PCR, followed by a direct sequencing of PCR products, was tested on DNA extracted from laboratory rats and mice lungs (ie, Rattus norvegicus and Mus musculus from Pasteur Institute of Lille, France) infected by P. carinii and P. murina, respectively [14] , and from lungs of wild rodents, obtained in the framework of the CERoPath ANR 07 BDIV 012 project, and infected by P. carinii, P. wakefieldiae, and other Pneumocystis species. Clinical samples were also screened for the presence of P. jirovecii by the new PCR assay and in-house nested PCR protocols, followed by a direct sequencing of PCR products. The patient material used in this study was collected between November 2012 and March 2013 at the Parasitology-Mycology Service of Lille-II University Hospital Center, Lille, France. It consisted of three oropharyngeal washings (OWs) and two bronchoalveolar lavage fluids (BALFs) from three patients previously tested positive for P. jirovecii by a real-time PCR assay (described elsewhere [15] ) without performing the first-round PCR step. To note, direct microscopic examination of one of the two BALF samples was positive for A. fumigatus. We also tested the new PCR on 10 clinical samples known to be negative by real-time PCR and nested PCR assays.
To further test the specificity of the novel PCR, five fungal DNA samples (Scedosporium aurantiacum, S. prolificans, R. oryzae, C. albicans, and Absidia corymbifera) were pooled and tested alone or together with P. carinii mtLSUrDNA plasmids in the novel and in-house PCRs.
Exhaustive measures were applied for all PCR assays to ensure that carryover contamination did not occur. These included the use of separate biosafety containment hoods and rooms for preparing specimens, setting up PCRs, and analyzing products; micropipettes with barrier tips; and several negative controls interspersed with specimens.
Results
The new primer pair
After analysis of various quality parameters of newly designed primer pairs, an optimal one was chosen, and its Pneumocystis specificity was verified by a BLAST search at the NCBI against the nr database (http://www.ncbi. nlm.nih.gov/). In order to amplify the longest fragment of the target, the best compromise we found was to conserve the reverse primer pAZ102-E from Wakefield et al. [1] and design a new forward primer, which we named pH207 (5 -ACAAATCGGACTAGGATATAGCTGGT-3 ).
When Primer-BLAST was used to check the target specificity of the new primer pair with the default specificity parameters, the primer pair showed a perfect match to numerous Pneumocystis spp. mtLSUrDNA sequences that would generate amplicons between 301-bp and 334-bp according to the Pneumocystis species amplified. Indeed, the new primers matched perfectly with mtLSUrDNA sequences from numerous Pneumocystis species or isolates such as Pneumocystis sp. from Microtus agrestis (GenBank AY279099), Sorex araneus (GenBank AY279101, AY279102, and AY279103), Apodemus sylvaticus (GenBank AY279097), Eliomys quercinus (GenBank AY279098), Talpa europae (GenBank AY279100), Capra hircus (GenBank AB602435), Microcoebus murinus (GenBank AY265388), Cercopithecus lhoesti (GenBank AY265382), Macaca nemestrina (GenBank AY265383), Saguinus fuscicollis (GenBank AF362462), Callimico goeldii (GenBank AF362461), Callithrix geoffroyi (GenBank AF362456), Saguinus midas midas (GenBank AF362455), P. carinii f. sp. carinii form 3 (GenBank U20171), and P. carinii f. sp. carinii form 4 (GenBank U20172); numerous P. jirovecii sequences; numerous Macaca fascicularis and rhesus macaques Pneumocystis-derived sequences; P. wakefieldiae (GenBank U20173); P. murina mitochondrial genome (GenBank NC_020332); P. carinii mitochondrial genomes (GenBank NC_013660 and JX499145); and P. jirovecii mitochondrial genomes (GenBank NC_020331, JX855938, JX855937, JX855936, and CAKN01000002).
When Primer-BLAST was performed against the NCBI nr database with organisms limited to other lung pathogens (see Materials and Methods section), no target templates were found, except for a 356-bp amplicon corresponding to a portion of the mitochondrial genome of R. oryzae (GenBank AY863212). However, there were up to five mismatches between primer pH207 and this target, which was, in our opinion, probably sufficient to prevent amplification interference or nonspecific amplification.
The qPCR assays performed to test the new primer pair displayed PCR efficiency that complied with the acceptance limits, with a limit of detection of two to five copies of mtLSUrRNA gene. Melting curve analysis revealed the specific amplicon melts at 78
PCR conditions
After optimization of the MgCl 2 concentration, the new endpoint PCR conditions that were considered optimal were as follows: To note, the comparison between PCR protocols showed a marked increase in speed of the new PCR program. Indeed, the new PCR gave a result in less than 2 h vs. 4 h for first-round PCR and 8 h for nested PCR.
PCR sensitivity and limit of detection of the novel PCR
By testing serial dilutions of P. carinii mtLSUrDNA plasmids in 25 ng of rat lung genomic DNA using the three PCR protocols, we first noted that the sensitivity of the novel PCR was not lower than the sensitivity of our in-house nested PCR (Table 1 ). The lowest concentrations of plasmid DNA that yielded PCR products using the new PCR were 2.10 0 plasmid copies, whereas our in-house single-round and nested PCRs detected 2.10 2 and 2.10 1 plasmid copies, respectively (Table 1 ; Fig. 2) . Moreover, the new PCR had more defined bands than the nested PCR (Fig. 2) .
The PCR results for the dilution series that contained from 2. plasmid copies with 80% sensitivity (8/10) but failed to detect 2.10 −1 plasmid copies (0/10; Table 1 ). All positive results were confirmed by direct sequencing of the PCR products. Negativity of controls that consisted of genomic DNA extracted from the lungs of noninfected rats and prepared along with the positive samples also confirmed the accuracy of the novel PCR (Table 1) .
PCR specificity of the novel PCR
The new PCR test on DNA extracted from laboratory or wild rodent lungs infected by P. murina, P. carinii, P. wakefieldiae, or other Pneumocystis species was conclusive in all cases. DNA sequencing of the positive amplicons confirmed the results of the PCR analysis (data not shown). New primers could successfully generate a 310-bp PCR product for P. carinii and a 318-bp PCR product for P. wakefieldiae and P. murina. No amplification was obtained from the new PCR when DNA extracted from Pneumocystis-free laboratory mice and rats was used as the template.
To compare the clinical performances of the three PCR assays, three OW and two BALF specimens collected from patients known to be positive for P. jirovecii by a real-time PCR were tested using the three methods. New primers produced PCR amplicons from P. jirovecii DNA of the expected size (ie, 301-bp PCR product) for all five samples. Interestingly, our in-house first-round PCR with primers pAZ-102H and pAZ102-E was positive for the two BALF samples but failed to detect P. jirovecii DNA in two of the three OWs. Our in-house nested PCR was positive for all five samples. Direct sequencing of the positive PCR products confirmed the results by obtaining P. jirovecii mtLSUrDNA sequences, even in the BALF sample coinfected with A. fumigatus. No amplification was obtained from the new PCR when it was tested on negative clinical samples.
To further address the question of specificity, we spiked a Pneumocystis-free lung DNA sample with a pool of fungal DNAs (S. aurantiacum, S. prolificans, R. oryzae, C. albicans, and A. corymbifera). No amplicons of the expected size (ie, 310 bp) were obtained from both previous and new PCRs. However, a product of approximately 360 bp was observed with the new PCR. Direct sequencing of this PCR product showed that this nonspecific band corresponded to a portion of the mitochondrial genome of R. oryzae (GenBank accession AY863212); as unfortunately, we might guess from the results of Primer-BLAST analysis (see Results section, New primer pair subsection). Of greater interest, no cross-amplification was obtained from both previous and new PCRs when 2.10 5 P. carinii mtLSUrDNA plasmid copies were added to the spiked DNA templates, and direct sequencing of these PCR products confirmed the amplification of P. carinii mitochondrial DNA.
Conclusion
Our results support the use of a single-round conventional PCR instead of nested PCR for detection of Pneumocystis spp. By designing this new amplification assay, the cost efficiency, turnaround time, contamination risk, and possibility of sequencing and technical errors are considerably reduced compared with the nested PCR reference method. This simple and rapid PCR assay, with the advantages of high sensitivity and Pneumocystis genus specificity, provides the opportunity to improve and standardize Pneumocystis detection and mtLSUrDNA direct sequencing in all laboratories. We propose the creation of a new open public resource that we term PneumoDB, which will centralize a comprehensive and curated collection of Pneumocystis mtLSUrDNA sequences, allowing Pneumocystis researchers instant access to a single unified resource (www. pegase-biosciences.com/collaborations/PneumoDB). This publicly accessible database will greatly enhance the use of mtLSUrRNA target sequences in epidemiological studies of Pneumocystis infection.
